Keywords

• Dapagliflozin powder
• Dapagliflozin price
• Dapagliflozin

Quick Details

• ProName: Dapagliflozin factory
• CasNo: 149506-35-4
• Molecular Formula: C21H25ClO6
• Appearance: white powder
• Application: in research
• DeliveryTime: within 3-5 days after receiving the pa...
• PackAge: Aluminum foil bag/ as requirements
• Port: China main port
• ProductionCapacity: 800 Kilogram/Month
• Purity: 99.00%
• Storage: Store in a cool dry place and keep awa...
• Transportation: by air or by sea
• LimitNum: 10 Gram

Superiority

       Inner Mongolia Yong Ming Technology Co.,Ltd--- a worthy to be depended and trusted Pharmaceutical Intermediates company. We make sure the good quality product and reasonable price. We have the good after-sales service, to solve any kinds of problems, the goal is making every customer satisfy with our company and gain the best reputation.

There are variety of products for your choose. Please contact with us at any time.

Our promise:

1. Good quality product and reasonable price~ make customers happy and save customers’ money

2. Delivery product on time~ save customers’ time

3. Professional packing~let the customers receive it successfully

4. Many payment instruments~convenient to pay 

5. Service customers forever~ to establish long-term cooperation relationship

Welcome to your inquire and suggestions, everyone here do the best for you!

Details

• Product Name: Dapagliflozin

  Cas No: 149506-35-4

  Molecular Formula: C21H25ClO6

  Appearance: white powder

  Application: Research purpose

  Delivery Time: within 1-3 working day

  Package: 1kg/Aluminum foil bag

  Production Capacity: 500 Kilogram/Month

  Purity: 98.5%Storage: Kept in a cool, dry and ventilated place

  .Transportation: by air

  Min order: 1 Gram

   

  Dapagliflozin , the trade name is Farxiga in the U.S. and Forxiga in the EU and Russia. It is a drug of the gliflozin class, used to treat type 2 diabetes. It was developed by Bristol-Myers Squibb in partnership with AstraZeneca.

   

   

  Mechanism of action 

  Dapagliflozin inhibits subtype 2 of the sodium-glucose transport proteins (SGLT2) which are responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter mechanism causes blood glucose to be eliminated through the urine.In clinical trials, dapagliflozin lowered HbA1c by 0.6 versus placebo percentage points when added to metformin.

   

  Selectivity

  The IC50 for SGLT2 is less than one thousandth of the IC50 for SGLT1 (1.1 versus 1390 nmol/L), so that the drug does not interfere with intestinal glucose absorption.

   

  Research

  Clinical trials to assess effectiveness for patients with type 1 diabetes are underway.

Welcome to your inquire, thanks in  advance.

More information: mona@nmg-ym.com

Skype: live:mona_3363